Di Nuzzo Private Wealth, Inc. Ironwood Pharmaceuticals Inc Transaction History

Di Nuzzo Private Wealth, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$5.58 - $8.61 $16 - $25	-3 Reduced 16.67%	15 $0
Q1 2024 May 06, 2024	BUY	$8.32 - $15.45 $8 - $15	1 Added 5.88%	18 $0
Q4 2023 May 06, 2024	SELL	$8.79 - $11.51 $8 - $11	-1 Reduced 5.56%	17 $195,000
Q4 2023 Feb 05, 2024	BUY	$8.79 - $11.51 $149 - $195	17 New	17 $195,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $562M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Di Nuzzo Private Wealth, Inc., based on Form 13F filings with the SEC.

Stay updated on Di Nuzzo Private Wealth, Inc. with notifications on news.